• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病与埃及上埃及地区患者的骨密度降低有关。

Non-alcoholic fatty liver disease is associated with decreased bone mineral density in upper Egyptian patients.

机构信息

Hepatology, Gastroenterology and Infectious Diseases Department, Faculty of Medicine, Al-Azhar University, Assiut, Egypt.

Rheumatology and Rehabilitation Department, Faculty of Medicine, Al-Azhar University, Assiut, Egypt.

出版信息

Sci Rep. 2023 Mar 16;13(1):4353. doi: 10.1038/s41598-023-31256-w.

DOI:10.1038/s41598-023-31256-w
PMID:36928441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10020438/
Abstract

Nonalcoholic fatty liver disease (NAFLD) has been linked with a number of extra hepatic diseases and could be a potential risk factor of decreasing bone mineral density. To determine whether Upper Egyptian patients with NAFLD are at risk of developing osteoporosis. Cross sectional study was done on a total 100 individuals; 50 patients diagnosed with NAFLD (based on ultrasound imaging) crossed-matched with 50 individuals without NAFLD based on age, sex and body mass index. Bone mineral density, serum calcium and phosphorus levels, serum parathyroid hormone, serum vitamin D and fasting insulin level were assessed. Osteoporosis was prevalent in NAFLD patients versus to controls (19/50 vs. 0/50; P < 0.001). There was significant decrease in bone mineral density in NAFLD patients than controls (- 2.29 ± 0.4 vs. - 1.53 ± 0.1; P < 0.001). There was a statistical significance decrease in serum vitamin D and calcium levels in NAFLD patients than controls. Furthermore, vitamin D levels in the NAFLD group was a predictor for osteoporosis (OR 0.614; 95% CI 0.348-0.825). Patients with NAFLD tend to have a significant decrease in bone density, vitamin D, and serum calcium levels than controls.

摘要

非酒精性脂肪性肝病(NAFLD)与许多肝外疾病有关,可能是降低骨密度的潜在危险因素。为了确定埃及上尼罗地区的 NAFLD 患者是否有发生骨质疏松的风险。本研究为一项横断面研究,共纳入了 100 人;50 名经超声成像诊断为 NAFLD 的患者(基于年龄、性别和体重指数与 50 名非 NAFLD 患者进行了交叉匹配。评估了骨密度、血清钙和磷水平、甲状旁腺激素、血清维生素 D 和空腹胰岛素水平。与对照组相比,NAFLD 患者的骨质疏松症更为常见(19/50 比 0/50;P<0.001)。与对照组相比,NAFLD 患者的骨密度显著降低(-2.29±0.4 比-1.53±0.1;P<0.001)。与对照组相比,NAFLD 患者的血清维生素 D 和钙水平显著降低。此外,NAFLD 组的维生素 D 水平是骨质疏松症的预测因素(OR 0.614;95%CI 0.348-0.825)。与对照组相比,NAFLD 患者的骨密度、维生素 D 和血清钙水平显著降低。

相似文献

1
Non-alcoholic fatty liver disease is associated with decreased bone mineral density in upper Egyptian patients.非酒精性脂肪性肝病与埃及上埃及地区患者的骨密度降低有关。
Sci Rep. 2023 Mar 16;13(1):4353. doi: 10.1038/s41598-023-31256-w.
2
Independent associations of low 25 hydroxy vitamin D and high parathyroid hormonal levels with nonalcoholic fatty liver disease in Asian Indians residing in north India.在印度北部居住的印度裔人群中,低 25 羟维生素 D 和高甲状旁腺激素水平与非酒精性脂肪性肝病存在独立关联。
Atherosclerosis. 2013 Sep;230(1):157-63. doi: 10.1016/j.atherosclerosis.2013.07.006. Epub 2013 Jul 22.
3
The relationship between fatty liver index and bone mineral density in Koreans: KNHANES 2010-2011.韩国人脂肪肝指数与骨密度的关系:KNHANES 2010-2011。
Osteoporos Int. 2018 Jan;29(1):181-190. doi: 10.1007/s00198-017-4257-z. Epub 2017 Oct 19.
4
Bone metabolism in non-alcoholic fatty liver disease: vitamin D status and bone mineral density.非酒精性脂肪性肝病中的骨代谢:维生素D状态与骨密度
Minerva Endocrinol. 2017 Jun;42(2):164-172. doi: 10.23736/S0391-1977.16.02587-6. Epub 2016 Dec 14.
5
Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?非酒精性脂肪性肝病与骨密度降低:二者有关联吗?
J Endocrinol Invest. 2015 Aug;38(8):817-25. doi: 10.1007/s40618-015-0315-6. Epub 2015 May 24.
6
Nonalcoholic fatty liver disease and osteoporosis: a systematic review and meta-analysis.非酒精性脂肪性肝病与骨质疏松症:一项系统综述和荟萃分析
J Bone Miner Metab. 2017 Nov;35(6):685-693. doi: 10.1007/s00774-016-0807-2. Epub 2016 Dec 7.
7
Vitamin D Status and Bone Mineral Density in Obese Children with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病肥胖儿童的维生素D状况与骨密度
J Korean Med Sci. 2015 Dec;30(12):1821-7. doi: 10.3346/jkms.2015.30.12.1821. Epub 2015 Nov 30.
8
Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation.接受原位肝移植的肝硬化患者的骨质疏松症和骨矿物质代谢紊乱
Calcif Tissue Int. 1997 Feb;60(2):148-54. doi: 10.1007/s002239900205.
9
Liver fibrosis is associated with impaired bone mineralization and microstructure in obese individuals with non-alcoholic fatty liver disease.肝纤维化与非酒精性脂肪性肝病肥胖个体的骨矿化和微观结构受损有关。
Hepatol Int. 2023 Apr;17(2):357-366. doi: 10.1007/s12072-022-10461-1. Epub 2022 Dec 15.
10
Association between nonalcoholic fatty liver disease and bone mineral density in postmenopausal women.绝经后女性非酒精性脂肪性肝病与骨密度之间的关联
Climacteric. 2018 Oct;21(5):498-501. doi: 10.1080/13697137.2018.1481380. Epub 2018 Aug 20.

引用本文的文献

1
Nonlinear Association Between Serum Uric Acid and Femoral Neck Bone Mineral Density in Male Patients with Metabolic Dysfunction-Associated Fatty Liver Disease.代谢功能障碍相关脂肪性肝病男性患者血清尿酸与股骨颈骨密度的非线性关联
Diabetes Metab Syndr Obes. 2025 Jan 17;18:161-171. doi: 10.2147/DMSO.S492060. eCollection 2025.
2
Effects of Metabolic Dysfunction-Associated Steatotic Liver Disease on Bone Density and Fragility Fractures: Associations and Mechanisms.代谢功能障碍相关脂肪性肝病对骨密度和脆性骨折的影响:关联及机制
J Obes Metab Syndr. 2024 Jun 30;33(2):108-120. doi: 10.7570/jomes24004. Epub 2024 May 14.
3
Anti-osteoporotic treatments in the era of non-alcoholic fatty liver disease: friend or foe.非酒精性脂肪性肝病时代的抗骨质疏松治疗:是敌是友。
Front Endocrinol (Lausanne). 2024 Mar 8;15:1344376. doi: 10.3389/fendo.2024.1344376. eCollection 2024.

本文引用的文献

1
Relationship between prevalence and risk of osteoporosis or osteoporotic fracture with non-alcoholic fatty liver disease: A systematic review and meta-analysis.非酒精性脂肪性肝病与骨质疏松症或骨质疏松性骨折患病率及风险的关系:系统评价和荟萃分析。
Osteoporos Int. 2022 Nov;33(11):2275-2286. doi: 10.1007/s00198-022-06459-y. Epub 2022 Jun 28.
2
Prevalence and Trends in Low Bone Density, Osteopenia and Osteoporosis in U.S. Adults With Non-Alcoholic Fatty Liver Disease, 2005-2014.2005-2014 年美国非酒精性脂肪性肝病患者低骨密度、骨量减少和骨质疏松症的流行率和趋势。
Front Endocrinol (Lausanne). 2022 Jan 19;12:825448. doi: 10.3389/fendo.2021.825448. eCollection 2021.
3
Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of osteoporosis and bone fractures.非酒精性脂肪性肝病(NAFLD)与骨质疏松症和骨折的发生率增加有关。
Z Gastroenterol. 2022 Aug;60(8):1221-1227. doi: 10.1055/a-1482-9236. Epub 2021 Oct 28.
4
Nonalcoholic fatty liver disease is associated with the development of obstructive sleep apnea.非酒精性脂肪性肝病与阻塞性睡眠呼吸暂停的发生有关。
Sci Rep. 2021 Jun 29;11(1):13473. doi: 10.1038/s41598-021-92703-0.
5
Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies.非酒精性脂肪性肝病与肝外癌症发病风险增加:观察性队列研究的荟萃分析
Gut. 2022 Apr;71(4):778-788. doi: 10.1136/gutjnl-2021-324191. Epub 2021 Mar 8.
6
Association between non-alcoholic fatty liver disease-associated hepatic fibrosis and bone mineral density in postmenopausal women with type 2 diabetes or impaired glucose regulation.非酒精性脂肪性肝病相关肝纤维化与 2 型糖尿病或糖调节受损绝经后妇女骨密度的关系。
BMJ Open Diabetes Res Care. 2020 Aug;8(1). doi: 10.1136/bmjdrc-2019-000999.
7
Increased risk of low bone mineral density in patients with non-alcoholic fatty liver disease: a cohort study.非酒精性脂肪性肝病患者骨密度降低风险增加:一项队列研究。
Eur J Endocrinol. 2020 Feb;182(2):157-164. doi: 10.1530/EJE-19-0699.
8
Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病的肝外表现。
Gut Liver. 2020 Mar 15;14(2):168-178. doi: 10.5009/gnl19069.
9
Association Between Nonalcoholic Fatty Liver Disease and Reduced Bone Mineral Density in Children: A Meta-Analysis.非酒精性脂肪肝与儿童骨密度降低的相关性:一项荟萃分析。
Hepatology. 2019 Sep;70(3):812-823. doi: 10.1002/hep.30538. Epub 2019 Mar 18.
10
Systematic review with meta-analysis: non-alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density.系统评价和荟萃分析:非酒精性脂肪性肝病与骨质疏松性骨折史相关,但与低骨密度无关。
Aliment Pharmacol Ther. 2019 Feb;49(4):375-388. doi: 10.1111/apt.15087. Epub 2019 Jan 1.